The leukotrienes and tumor necrosis factor (TNF) play an important role in the pathophysiology of septic shock, in which hypotension, leukopenia, thrombocytopenia, and hemoconcentration are observed. This study was performed to examine the effects of a 5-lipoxygenase inhibitor (AA-861), a selective leukotriene receptor antagonist (ONO-1078), and a cyclooxygenase inhibitor (indomethacin) on endotoxin-induced mortality and TNF production in mice. The 50%o lethal dose of LPS in the mice treated with dimethyl sulfoxide or ethanol was 32 or 33 ,g, respectively, and it increased to 83 ,Ig with AA-861 or 59 ,ug with ONO-1078, respectively. Neither AA-861 nor ONO-1078 suppressed LPS-induced TNF production in sera. Treatment with AA-861 significantly decreased the leukopenia and thrombocytopenia, and ONO-1078 significantly decreased the hemoconcentration and thrombocytopenia. The role of endogenous TNF was also examined in the carrageenan-pretreated mice. Treatment with 2 x IV U of rabbit anti TNF-o antibody intravenously 2 h before LPS challenge significantly suppressed the LPS-induced TNF activity and decreased the mortality. Therefore, both leukotrienes and TNF play important roles in endotoxin-induced shock and mortality.
The tumor necrosis factor (TNF) is an important cytokine that mediates endotoxin shock and causes multiple organ damage (5) . It has been reported that patients with peritonitis or burns are apt to go into septic shock and to develop multiple organ failure (13) . We previously reported that in mice pretreated intraperitoneally with carrageenan (CAR), a sulfated polygalactose, even a low dose of endotoxin (50 ,ug per mouse) caused enormous TNF production in serum and death (24) . It was supposed that inflammation played an important role in the enhancement of lipopolysaccharide (LPS)-induced TNF production and mortality caused by CAR pretreatment, because CAR is used as an inflammatory agent as well as a reticuloendothelial system blocker. These findings suggest that the inflammation plays an important role in the development of low-dose endotoxin-induced mortality and multiple organ failure and that CAR-pretreated mice provide a useful model to analyze the pathophysiological mechanism.
There is increasing recent evidence that inflammatory mediators such as leukotrienes (LTs) (8) (9) (10) 33) and cyclooxygenase products (2, 20) are involved in the pathophysiology of endotoxemia. It was reported that LT inhibitors suppressed LPS-induced TNF production and mortality in galactosamine-treated mice (30) .
2-(12-Hydroxydodeca-5,10-dinyl)-3,5,6-trimethyl-1,4-benzoquinone (AA-861) is a selective 5-lipoxygenase inhibitor that was reported to inhibit 5-lipoxygenase from guinea pig loxy)benzoylamino]-2-tetrazol-(5-yl)-4H-1-benzopyran hemihydrate (ONO-1078) is an LTC4D4 receptor antagonist that has been shown to selectively antagonize LT-induced bronchoconstriction in guinea pig and human bronchial smooth muscles (23) . The effect was 10 to 100 times stronger than that of the LT antagonist FPL-55712 (1). We therefore investigated the effect of AA-861, ONO-1078, and indomethacin on LPS-induced TNF production and mortality in CAR-pretreated mice. The present study shows that AA-861 and ONO-1078 cannot reduce the plasma TNF levels but can significantly reduce LPS-induced mortality of CAR-pretreated mice.
(Part of this study was presented at the Second Interna- (Fig. 1) . The cumulative percent mortality in mice receiving each dose of LPS was determined by counting the dead mice at 72 h after LPS injection (Fig. 2) . Statistics A significant difference was presumed at a probability value of <0.05. The maximum soluble doses were 0.6 mmol/ml in 10% DMSO for AA-861 and 1.2 mmol/ml in 10% ethanol for ONO-1078. These solutions were used as the maximum doses for the treatments. The mortality of mice was significantly decreased in AA-861-ONO-1078-treated mice relative to that in the control mice (chi-square test; Table 1 ). However, we could not find any significant difference between vehicle-and indomethacin-treated mice in mortality. Although both AA-861 and ONO-1078 s.c. treatments 1 h before LPS (50 p,g) injection significantly decreased the LPS-induced mortality, the treatments 1 h after the LPS injection did not do so (data not shown).
RESULTS
Effects of 5-lipoxygenase inhibitor (AA-861) or LTC4D4 antagonist (ONO-1078) on survival curves of mice in endotoxin shock Pretreatment with CAR (5 mg i.p.) rendered the mice more sensitive to the effect of LPS, as previously reported (24) . Although the survival rate of mice treated with each solvent was 20% at 72 h after LPS (50 p,g per mouse) administration, s.c. treatment with AA-861 (20 mmol/kg) or ONO-1078 (40 mmol/kg) significantly increased the survival rate after the LPS administration ( Fig. 1) h after endotoxin injection. There was no significant difference between the TNF activities at 2 h after LPS challenge. We could not find any significant differences between the TNF levels in AA-861-and ONO-1078-treated mice and control mice at 1, 3, or 4 h (data not shown). There was also no significant difference between the TNF levels in mice treated with saline, DMSO, or ethanol (data not shown).
Effects of anti-TNF-a antibody on LPS-induced mortality in CAR-pretreated mice. For this experiment, each mouse received CAR (5 mg) and then LPS (50 pg) 24 h later. Control mice were injected i.v. with 0.2 ml of normal rabbit serum 2 h before the LPS challenge. The other mice were injected i.v. with 2 x 105 U of anti-TNF-a antibody 2 h before the LPS challenge. The treatment with 2 x 10 U of anti-TNF-a antibody significantly suppressed the LPS-induced TNF activity in sera and decreased the mortality ( Table 2) .
Effects of AA-861 and ONO-1078 on the hematological response. The effects of AA-861 or ONO-1078 on the hematological response are summarized in Table 3 . The endotoxin-induced leukopenia and thrombocytopenia in the LPSchallenged group were significantly greater than those in the control group. The number of leukocytes in AA-861-treated mice was significantly higher than that in the control group at 30 min after LPS administration. The leukopenia remained until 4 h after LPS injection, but no significant difference was found between the AA-861-or ONO-1078-treated group and DISCUSSION The present data show that both AA-861 and ONO-1078 reduce the mortality rate without suppressing endotoxininduced TNF production. The drugs attenuated the thrombocytopenia, leukopenia, and the early vascular permeability that were caused by endotoxin in CAR-pretreated mice. These findings suggest that LTs exerted an important role in determining the endotoxin-induced mortality in CAR-pretreated mice.
It has been reported that lipoxygenase inhibitors suppress TNF production in galactosamine-treated mice (30) . Our present data, however, showed that the lipoxygenase inhibitor AA-861 or the LTC4D4 antagonist ONO-1078 suppressed endotoxin-induced mortality despite the elevated TNF activity in sera, indicating that LTs influenced the LPS-induced mortality rate but not LPS-induced TNF production in CAR-pretreated mice. It has been reported that interleukin-6 in serum is dramatically elevated by LPS stimulation in CAR-pretreated mice (12) . These findings suggest that inflammatory mediators play a key role in endotoxin-induced mortality in CAR-pretreated mice. Our study, however, demonstrated that a cyclooxygenase inhibitor (indomethacin) could not decrease the rate of LPSinduced mortality in CAR-pretreated mice. We conclude that the role of LTs is more important than that of cyclooxygenase products in the mortality of CAR-pretreated mice.
Recently, Franks et al. reported that anti-TNF-ot antibody could not prevent LPS-induced mortality in CAR-pretreated mice. In their experiment 4 x 105 U of rabbit anti-TNF-a antibody was injected i.p. 5 h before LPS challenge. Our data, however, demonstrated that treatment with 2 x 10 U of rabbit anti-TNF-ax antibody i.v. 2 h before LPS challenge significantly reduced LPS-induced mortality and the TNF activity in sera. The discrepancy between the data of Franks et al. and our data might be due to differences in the time intervals and routes of the anti-TNF-a antibody injection and the experimental model with CAR. Franks et al. injected lambda-CAR (1 mg) i.p. into BALB/c mice and challenged the mice with LPS (2 ,ug) 1 h later. In our experiment, anti-TNF-a antibody significantly suppressed the TNF activity in sera and prevented death. Thus, TNF plays an important role in low-dose endotoxin-induced shock and death even in CAR-pretreated mice.
We wanted to know how AA-861 or ONO-1078 affected the reduction of the endotoxin-induced mortality in CARpretreated mice. Hagmann et al. reported that production of LTs was enhanced by endotoxin (18) and that LTs were eliminated into the bile (17) . Endotoxin is known to cause hemoconcentration, leukopenia, and thrombocytopenia, indicating increased vascular permeability, margination of leukocytes, and platelets in blood vessels, respectively. Our present data showed that the LT antagonist ONO-1078 somewhat decreased the LPS-induced hemoconcentration and thrombocytopenia and that the LT inhibitor AA-861 also decreased LPS-induced leukopenia and thrombocytopenia.
Exogenous administration of LTC4 and LTD4 has been reported to increase vascular permeability (22, 32) . Filep et al. demonstrated that LTC4 or LTD4 increased the hematocrit in conscious rats (11) . Wendel and Tiegs reported that LTD4 plays an important role in galactosamine-endotoxininduced hepatitis (35) . Recently, an LT antagonist, LY 203647, prevented extravascular water accumulation in pig lungs in a septic shock model (8) . In addition, endotoxininduced hemoconcentration was reduced by the LT antagonist LY 171883 (9) or SK&F 104353 (33) . LTB4 also causes an increase in peripheral vascular permeability in rabbits, rats, guinea pigs, and hamsters (6) . LTB4 injected alone has little permeability-increasing effect in the skin; however, the LTB4 response is markedly enhanced by the presence of a vasodilator such as prostaglandin E2 (6) . In our results, the reduction of the endotoxin-induced hemocrit by the LTC4D4 antagonist ONO-1078 was stronger than that of the 5-lipoxygenase inhibitor AA-861. Therefore, these findings suggest that LTC4 and LTD4 play a predominant role in the enhancement of vascular permeability in an early phase after endotoxin administration.
Schraufstatter et al. reported that leukocytes are marginated in the pulmonary microcirculation and release protease, oxidants, and arachidonic acid metabolites during endotoxin shock (31) . LTB4 is one of the most potent chemoattractants of leukocytes (6) . We (14) . Our results suggest that inflammation is closely related to endotoxin-induced mortality in CAR-pretreated mice. Recently, it was reported that recombinant human TNF-ot alone was not lethal, but that synergy between TNF and bacterial products caused lethal shock in mice (26) . We believe that TNF probably involves synergism with LPS and other inflammatory mediators such as interleukin-1, interleukin-6, platelet-activating factor, and LTs and that such synergisms lead to the associated platelet activation, bronchoconstriction, hypotension, increased vascular permeability, and, eventually, death. Although we usually inject a large amount of LPS into experimental animals to elicit endotoxin shock, clinical observation suggested that a high level of serum endotoxin is not essential to develop shock and multiple organ failure (15, 16, 34) . It is supposed that inflammation (7, 13, 15, 16) and depression of the reticuloendothelial system (28, 29) are important factors in developing endotoxin-induced mortality and multiple organ damage in human patients. CAR-pretreated mice are available for the study of the pathophysiological mechanism of the low-dose endotoxin-induced shock and multiple organ failure, because even a small dose of LPS can enhance both the plasma TNF levels and the mortality rate in CAR-pretreated mice, as we previously reported (24) .
In summary, both an LT inhibitor (AA-861) and an LT antagonist (ONO-1078) significantly decreased endotoxininduced mortality in CAR-pretreated mice without suppressing the serum TNF activity. Treatment with anti-TNF-a antibody i.v. also decreased the LPS-induced mortality and suppressed TNF activity. We conclude that LTs and TNF are important mediators of endotoxin-induced mortality in CAR-pretreated mice.
